Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA · Nasdaq

Genenta Science S.p.A. (GNTA) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Genenta Science S.p.A. in 2026. The next earnings report is expected on September 2, 2026.

Earnings calendar

Next earnings date

02 Sep 2026

In 14 days

EPS estimate

-0.27

Revenue estimate

0

Past earnings

01 Apr 2026
EPS actual
—
estimate -0.36
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
25 Feb 2026
EPS actual
-0.36 (0.0%)
estimate -0.36
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.

Sector
Healthcare
Industry
Biotechnology
Country
Italy
Exchange
Nasdaq
CEO
Pierluigi Paracchi
Employees
13
IPO date
15 Dec 2021
ISIN
US36870W1009
Website
genenta.com

Frequently asked questions

When does Genenta Science S.p.A. (GNTA) next report earnings?

Genenta Science S.p.A. (GNTA) is scheduled to report earnings on September 2, 2026.

What was Genenta Science S.p.A.'s most recent earnings date?

Genenta Science S.p.A. (GNTA) last reported earnings on April 1, 2026.

Where is Genenta Science S.p.A. stock listed?

Genenta Science S.p.A. (GNTA) is listed on Nasdaq.